Ceronapril
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C30H46NO7P |
Molar mass | 563.672 g·mol−1 |
3D model (JSmol) | |
| |
|
Ceronapril (INN,[1] proposed trade names Ceranapril, Novopril) is a phosphonate ACE inhibitor[2] that was never marketed.[citation needed]
References
[edit]- ^ "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 31" (PDF). World Health Organization. p. 4. Retrieved 2 March 2017.
- ^ Tu JI, Brennan J, Stouffer B, Mantha S, Turabi N, Tsay HM (June 1992). "Radioimmunoassay for ceronapril, a new angiotensin-converting enzyme inhibitor, and its application to a pharmacokinetic study in healthy male volunteers". Therapeutic Drug Monitoring. 14 (3): 209–19. doi:10.1097/00007691-199206000-00007. PMID 1412607. S2CID 23854785.